Frequently Asked Questions
As pharmacies struggle to fulfill the demand for medicines during the covid-19 pandemic, 503B outsourcing facilities have proven crucial to health systems and hospital pharmacies during the covid-19 pandemic to help address drug scarcity and its impact on patients.
Increasing investments by the key market players in research and development will boost the growth of the US compounding pharmacy market as they innovate and customize formulations to treat various diseases effectively.
The phenylephrine segment had a major share in the market in 2022.
The Prefilled Syringes segment had a major share in the market.